In the News Poz: Generic PrEP Highlights How Even Low-Cost HIV Care Relies on High Drug Prices May 7, 2021 NASTAD's Tim Horn was included in this Poz article. Read the Article In the News An injectable HIV-prevention drug is highly effective — but wildly expensive Sep 12, 2024 Federal Agency Limits HIV Community's Ability to Offer Input on New Strategy Sep 5, 2024 20 Years of Truvada: A (Nearly Exhaustive) Timeline Aug 5, 2024
